Alteration of somatostatin but not growth hormone-releasing factor pituitary binding sites in obese Zucker rats.
The present study was designed to determine whether the diminution of growth hormone (GH) secretion that occurs in obese Zucker rats is related to alterations of GH-releasing factor (GRF) or somatostatin (SRIF) pituitary binding sites. Cold saturation studies were performed in pituitary homogenates of 4-month-old lean and obese rats, using [125I-Tyr10]hGRF(1-44)NH2 as radioligand and [127I-Tyr10]hGRF-(1-44)NH2 as competitor, and in pituitary membrane preparations, using [125I-Tyr0, D-Trp8]SRIF14 as radioligand and [127I-Tyr0, D-Trp8]SRIF14 as competitor. In lean rats, analysis of the curves by the Ligand program revealed the presence of two distinct classes of GRF binding sites, the first being of high affinity (0.74 +/- 0.11 nM) and low capacity (118 +/- 31 fmol/mg protein), the second being of lower affinity (880 +/- 240 nM) and higher capacity (140 +/- 35 pmol/mg protein), and of a single class of SRIF binding sites (affinity: 0.40 +/- 0.12 nM; capacity: 24 +/- 6 fmol/mg protein). In obese rats, no difference was observed in GRF binding parameters for both classes of sites, but the concentration of somatostatin binding sites was reduced by 67% when compared to their lean littermates. These findings suggest that the SRIF pituitary receptors are down-regulated in obese Zucker rats and indicate that no alteration of GRF pituitary binding sites contribute to the blunted GH secretion observed in this model of obesity.
Abribat
T
T
Neuroendocrinology Laboratory, Notre-Dame Hospital Research Center, University of Montreal, Canada.
Finkelstein
J A
JA
Gaudreau
P
P
D000818:Animals; D015536:Down-Regulation; D013007:Growth Hormone-Releasing Hormone / Q000031:analogs & derivatives / Q000378:metabolism; D008297:Male; D009479:Neuropeptides / Q000378:metabolism*; D010902:Pituitary Gland / Q000737:chemistry*; D051381:Rats; D011924:Rats, Zucker / Q000502:physiology*; D018013:Receptors, Neuropeptide; D017981:Receptors, Neurotransmitter / Q000032:analysis*; D018017:Receptors, Pituitary Hormone-Regulating Hormone; D017481:Receptors, Somatostatin; D013004:Somatostatin / Q000031:analogs & derivatives / Q000378:metabolism; D013347:Subcellular Fractions / Q000737:chemistry
D009479:Neuropeptides; D018013:Receptors, Neuropeptide; D017981:Receptors, Neurotransmitter; D018017:Receptors, Pituitary Hormone-Regulating Hormone; D017481:Receptors, Somatostatin; C062925:somatotropin releasing hormone (1-45); D013004:Somatostatin; C012088:somatostatin, N-Tyr(1)-; D013007:Growth Hormone-Releasing Hormone; C048250:somatotropin releasing hormone receptor